CCR4 blockade leads to clinical activity and prolongs survival in a canine model of advanced prostate cancer
S. Maeda, T. Motegi, A. Iio, K. Kaji, Y. Goto-Koshino, S. Eto, N. Ikeda, T. Nakagawa, R. Nishimura, T. Yonezawa, Y. Momoi
The paper shows that blocking CCR4 reduces Treg infiltration and improves survival in a canine model of advanced prostate cancer.
bioRxiv · Apr 12, 2021 · PreprintCancer Biology